1 – 10 of 40
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
(
- Contribution to journal › Article
-
Mark
Lipid Metabolic Reprogramming Extends beyond Histologic Tumor Demarcations in Operable Human Pancreatic Cancer
(
- Contribution to journal › Article
- 2021
-
Mark
Predicting molecular phenotypes from histopathology images : A transcriptome-wide expression–morphology analysis in breast cancer
(
- Contribution to journal › Article
-
Mark
The Irradiated brain microenvironment supports glioma stemness and survival via astrocyte-derived transglutaminase 2
(
- Contribution to journal › Article
- 2019
-
Mark
An orally active galectin-3 antagonist inhibits lung adenocarcinoma growth and augments response to PD-L1 blockade
(
- Contribution to journal › Article
- 2018
-
Mark
Patient-derived xenograft models reveal intratumor heterogeneity and temporal stability in neuroblastoma
(
- Contribution to journal › Article
- 2017
-
Mark
SOX5/6/21 prevent oncogene-driven transformation of brain stem cells
(
- Contribution to journal › Article
-
Mark
Acquired immune resistance follows complete tumor regression without loss of target antigens or IFNγ signaling
(
- Contribution to journal › Article
-
Mark
Therapeutic rationale to target highly expressed CDK7 conferring poor outcomes in triple-negative breast cancer
(
- Contribution to journal › Article
- 2016
-
Mark
TPL2 is an oncogenic driver in keratocanthoma and squamous cell carcinoma
(
- Contribution to journal › Article